Concepedia

A Cross-Sectional Study of the Prevalence of Cardiac Valvular Abnormalities in Hyperprolactinemic Patients Treated With Ergot-Derived Dopamine Agonists

William M Drake, Craig E Stiles, Trevor A. Howlett, Andrew Toogood, John S. Bevan, Richard P. Steeds

The Journal of Clinical Endocrinology & Metabolism · 2013 · 65 citations · 20 references

DOIFull text

Open access

Abstract

This large UK cross-sectional study does not support a clinically concerning association between the use of dopamine agonists for the treatment of hyperprolactinemia and cardiac valvulopathy.

References

20

Burden of valvular heart diseases: a population-based study

Vuyisile T. Nkomo, Julius M. Gardin, Thomas N. Skelton et al. · The Lancet · 2006 · 4.7K citations

, , +5

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

R Zanettini, Angelo Antonini, Gemma Gatto et al. · New England Journal of Medicine · 2007 · 874 citations · Full text

Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation

R Schade, Frank Andersohn, Samy Suissa et al. · New England Journal of Medicine · 2007 · 708 citations

Carcinoid Heart Disease

Paul A. Robiolio, Vera H. Rigolin, John S. Wilson et al. · Circulation · 1995 · 403 citations

Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease

Guy Van Camp, Anja Flamez, Bernard Cosyns et al. · The Lancet · 2004 · 320 citations

, , +1